Dec. 12, 2003 — Editor's Note: On Nov. 14, Eyeonics, Inc., received U.S. Food and Drug Administration (FDA) approval to market the first accommodating intraocular lens (Crystalens) that allows ...

A cataract is the opacification of the eye's natural lens. It usually develops over a period of time, causing a gradual deterioration in eyesight, and may eventually lead to blindness. Surgical ...

Please provide your email address to receive an email when new articles are posted on . Ophthalmologists have been searching for effective ways to address presbyopia for many decades, particularly ...

Please provide your email address to receive an email when new articles are posted on . In 2013, Malvina B. Eydelman, MD, director of the FDA’s Division of Ophthalmic and Ear, Nose and Throat Devices, ...

Intraocular lenses (IOLs), implanted in the eye as treatment for cataracts or myopia, are a growing global market in an ageing population, one estimated to be worth more than $4.5 billion by 2022.

LensGen, a California-based developer of intraocular lenses (IOL) for the treatment of presbyopia and cataracts, has announced the release of $11 million in Series A funding. The funds are part of the ...

Among many presentations during a hot topics session at the American Academy of Ophthalmology 2021 annual meeting, speakers discussed the first FDA approved therapy for thyroid eye disease and the ...

Cataracts are incredibly common among older adults. More than half of all Americans over age 80 either have cataracts or have had surgery to remove them. “They are a common eye condition where the ...

Clear lens extraction (CLE)—also known as refractive lensectomy or refractive lens exchange—is similar to cataract surgery. Both CLE and cataract surgery involve removing your eye's natural lens and ...